BAG3 Mutation Associated Dilated Cardiomyopathy Clinical Trials

3 clinical trials for BAG3 Mutation Associated Dilated Cardiomyopathy across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM) — RECRUITING · PHASE1
• ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy — RECRUITING · PHASE1
• A Phase 1/2, Open-Label, Dose Finding Study to Investigate the Safety, Tolerability, and Efficacy of ALXN2350 Gene Therapy in Adult Participants with Symptomatic BAG3 Mutation-Associated Dilated Cardiomyopathy — RECRUITING · PHASE2

Refine this search